Table 6.
Reports of BCRP transporter sensitivity for some PET radioligands in various species, based on in vitro assays and on in vivo, mainly PET, studies.
Radioligand | Imaging target | In vivo species | In vitro species | Substrate (Yes/No) | Reference |
---|---|---|---|---|---|
[18F]MPPF | 5-HT1A | M (g) | No | [194] | |
[18F]MPPF | 5-HT1A | H (c) | No | [197] | |
[11C]WAY | 5-HT1A | H (c) | No | [197] | |
[11C]PIB | Aβ | H (c) | No | [197] | |
[11C]Flumazenil | Bz | H (c) | No | [197] | |
[18F]Fallypride | D2/D3 | H (c) | No | [197] | |
[11C]Raclopride | D2/D3 | H (c) | No | [197] | |
[11C]Befloxatone | MAO-A | R (g) | No | [205] | |
[11C]Befloxatone | MAO-A | H (c) | Yes | [197] | |
[11C]PK11195 | TSPO | H (c) | No | [197] |
M = Mouse, R = Rat; H = Human.
c = cell-based assay; g = efflux transporter knockout.